Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and ot
| Current Price | ₹1,198.80 |
|---|---|
| Market Cap | ₹32,230 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 58 |
| Return on Equity | 15.03% |
| 52-Week Range | ₹956.00 – ₹1,456.50 |
| Beta (1Y) | 0.24 |
| Dividend Yield | 0.04% |
1. The Healthcare Services-100%
Global Health Ltd (Medanta) is trading at ₹1,198.80, with a market capitalisation of ₹32,230 Cr.
Global Health Ltd (Medanta) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Global Health Ltd (Medanta) has a P/E of 58 and a return on equity of 15.03%.